Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitreosolve for Inducing Posterior Vitreous Detachment in Diabetic Retinopathy
NCT00908778Phase 3Unknown
- Sponsor
- VitreoRetinal Technologies, Inc.
- Start
- Oct 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Vitreosolve in diabetic retinopathy (DR), sponsored by VitreoRetinal Technologies, Inc.. Status: unknown.
02
Drugs
Vitreosolve
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT00908778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908778.